FA | CHOP Research Institute
 

FA

Published on
May 19, 2023
CHOP research paved the way for the first treatment for Friedreich’s ataxia (FA), an inherited neurodegenerative disease.

The Lynch Lab conducts clinical, translational, and basic science research on the rare disease Friedreich ataxia

Published on
Oct 15, 2020
Peter Kurre, MD, seeks to determine to what extent defects in fetal blood forming cells accelerate the loss of bone marrow function in young patients.

Dr. Lynch maintains a dynamic program that involves clinical, translational, and basic science research efforts focused on the rare disease Friedreich ataxia.

E-mail:
lynch [at] chop.edu
Published on
Oct 27, 2017
"There is a great sense of community and interconnectedness among the folks who are here," said an attendee of the 10th Annual Friedreich's Ataxia Symposium.
Published on
Jul 29, 2016
Welcome back to another weekly edition of our roundup of research news from The Children's Hospital of Philadelphia! One of the things that is so exciting about research at CHOP is that our researchers are working to improve the health and lives of children in such a broad range of ways.